Cargando…

Alloimmune Risk Stratification for Kidney Transplant Rejection

Different types of kidney transplantations are performed worldwide, including biologically diverse donor/recipient combinations, which entail distinct patient/graft outcomes. Thus, proper immunological and non-immunological risk stratification should be considered, especially for patients included i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bestard, Oriol, Thaunat, Olivier, Bellini, Maria Irene, Böhmig, Georg A., Budde, Klemens, Claas, Frans, Couzi, Lionel, Furian, Lucrezia, Heemann, Uwe, Mamode, Nizam, Oberbauer, Rainer, Pengel, Liset, Schneeberger, Stefan, Naesens, Maarten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163827/ https://www.ncbi.nlm.nih.gov/pubmed/35669972 http://dx.doi.org/10.3389/ti.2022.10138

Ejemplares similares

European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group
por: Mamode, Nizam, et al.
Publicado: (2022)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
por: Seron, Daniel, et al.
Publicado: (2022)

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
por: Roufosse, Candice, et al.
Publicado: (2022)

Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
por: Bestard, Oriol, et al.
Publicado: (2023)

European Society for Organ Transplantation (ESOT)-TLJ 3.0 Consensus on Histopathological Analysis of Pre-Implantation Donor Kidney Biopsy: Redefining the Role in the Process of Graft Assessment
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe
por: Rostaing, Lionel P. E., et al.
Publicado: (2023)

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
por: Delpire, Boris, et al.
Publicado: (2022)

Editorial: Transplant International Goes for GOLD!
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Editorial: Rubies for ESOT!
por: Berney, Thierry, et al.
Publicado: (2022)

Reflecting on an Intense Year for Transplant International
por: Berney, Thierry, et al.
Publicado: (2022)

Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials
por: Becker, Jan Ulrich, et al.
Publicado: (2022)

Xenotransplantion: Defeating the “Shumway Curse” An Interview With Drs. Bartley Griffith, Jayme Locke, Robert Montgomery, and Bruno Reichart
por: Berney, Thierry, et al.
Publicado: (2022)

ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
por: Cillo, Umberto, et al.
Publicado: (2022)

Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023)

Novel insights into non‐HLA alloimmunity in kidney transplantation
por: Reindl‐Schwaighofer, Roman, et al.
Publicado: (2019)

Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation
por: Sebagh, Mylène, et al.
Publicado: (2023)

Eliminating Race From eGFR Calculations: Impact on Living Donor Programs
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines
por: Couzi, Lionel, et al.
Publicado: (2023)

Donating a Kidney to a Stranger: Are Healthcare Professionals Facilitating the Journey? Results From the BOUnD Study
por: Maple, Hannah, et al.
Publicado: (2023)

Back to the Future With Co-Stimulation Blockade
por: Flechner, Stuart M., et al.
Publicado: (2023)

Is Preemptive Kidney Transplantation Associated With Improved Outcomes when Compared to Non-preemptive Kidney Transplantation in Children? A Systematic Review and Meta-Analysis
por: Rana Magar, Reshma, et al.
Publicado: (2022)

Living Donor Kidney Transplantation in Older Individuals: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View
por: Courtney, Aisling E., et al.
Publicado: (2023)

The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
por: van den Broek, Dennis A. J., et al.
Publicado: (2023)

Monomethyl fumarate prevents alloimmune rejection in mouse heart transplantation by inducing tolerogenic dendritic cells: Monomethyl fumarate prevents alloimmune rejection
por: Chen, Juntao, et al.
Publicado: (2023)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Embracing the Wisdom of Ancient Greece in the Era of Personalized Medicine—Uncertainty, Probabilistic Reasoning, and Democratic Consensus
por: Naesens, Maarten
Publicado: (2023)

Donor Autonomy and Self-Sacrifice in Living Organ Donation: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View
por: Mamode, Nizam, et al.
Publicado: (2022)

Exploring Staff Attitudes Towards Unspecified Kidney Donors in the United Kingdom: Results From the BOUnD Study
por: Zuchowski, Mira, et al.
Publicado: (2023)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Equity, Diversity and Inclusion (EDI) in Organ Transplantation: An ESOT Survey About EDI Within ESOT as an Organization and its Educational Activities, and Transplantation Research and Science
por: Pengel, L. H. M., et al.
Publicado: (2023)

Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection
por: Wiebe, Chris, et al.
Publicado: (2020)

Impact of COVID-19 on Global Kidney Transplantation Service Delivery: Interim Report
por: Papalois, Vassilios, et al.
Publicado: (2022)

The Role of the Duffy Blood Group Antigens in Renal Transplantation and Rejection. A Mini Review
por: Hariri, Dana, et al.
Publicado: (2023)

Application of Intestinal Barrier Molecules in the Diagnosis of Acute Cellular Rejection After Intestinal Transplantation
por: Chen, Yun, et al.
Publicado: (2023)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
por: van Vugt, Lukas K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_irc73phuo728bpg5nj6p9k9j7n